News

March 12 - 14, 2025, Novotel London West, UK
Nextgen Biomed 2025



GeneFrontier participated in Nextgen Biomed 2025 as a sponsor.
Also, GeneFrontier presented the latest PUREfrex® technology at the conference as a speaker.



“Unleashing The Power Of Cell-Free: PUREfrex® For Protein Engineering & Discovery”
Takashi Ebihara, PhD, COO, GeneFrontier Corporation

PUREfrex® is our unique rebuilt cell-free protein expression system. It’s easy to customize for various applications, and useful for high throughput screening of various kinds of biologics, difficult-to-express protein or novel modalities having the synergy with the AI/ML platform.



The presentation materials available from the link below.